Long-form articles on clinical trial operations, covering patient enrollment, site sustainability and where trial research is heading. Draws on conference observations from SCRS 2026 and trend analysis aimed at sponsors, CROs and research sites.
Website: https://7.cr/
PulmCCM covers critical care and pulmonary medicine, with critical appraisals of new trials, regulatory developments, and case-based teaching questions. Readers get detailed breakdowns of study design, results, and limitations, plus CME-oriented learning content.
A retired cardiologist and former FDA official documents his personal effort to find a Parkinson's treatment, mixing commentary on recent trial results with his own research history and operational updates on drug development. Readers get a firsthand, detailed view of how a non-specialist approaches PD science and what regulatory and safety steps a potential drug must clear.
A daily-style biopharma newsletter offering commentary on therapeutics, regulatory oversight and clinical trials, organised around weekday themes. Readers get a short, opinionated take on industry developments such as biosimilar choices, regulator priorities and upcoming conference data.
MD Reports, by independent journalist Marianne Demasi, publishes investigations into science and medicine, including vaccine policy, trial conduct and drug evidence. Issues dig into primary documents such as trial protocols, regulatory records and committee minutes, though the sample is heavily framed around a critical stance toward institutions.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
